first i've heard about immunogenicity concern although i'm admittedly illiterate in the biotech field.
wondering what people's opinions are as to time line to address and whether premarket price level ~$6.70 reduces MNTA to 'opportunity' level for future products (if Yahoo is to be believed, cash value is about $4).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.